These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 7884894)

  • 1. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules.
    Battegay M; Fikes J; Di Bisceglie AM; Wentworth PA; Sette A; Celis E; Ching WM; Grakoui A; Rice CM; Kurokohchi K
    J Virol; 1995 Apr; 69(4):2462-70. PubMed ID: 7884894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
    Cerny A; McHutchison JG; Pasquinelli C; Brown ME; Brothers MA; Grabscheid B; Fowler P; Houghton M; Chisari FV
    J Clin Invest; 1995 Feb; 95(2):521-30. PubMed ID: 7860734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.
    Kurokohchi K; Akatsuka T; Pendleton CD; Takamizawa A; Nishioka M; Battegay M; Feinstone SM; Berzofsky JA
    J Virol; 1996 Jan; 70(1):232-40. PubMed ID: 8523531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
    J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
    J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes.
    Sarobe P; Huarte E; Lasarte JJ; López-Díaz de Cerio A; García N; Borrás-Cuesta F; Prieto J
    J Hepatol; 2001 Feb; 34(2):321-9. PubMed ID: 11281563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
    Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA
    J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.
    Guo Z; Zhang H; Rao H; Jiang D; Cong X; Feng B; Wang J; Wei L; Chen H
    PLoS One; 2012; 7(6):e38390. PubMed ID: 22701633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.
    Wang Y; Takao Y; Harada M; Yutani S; Ide T; Sata M; Itoh K; Yamada A
    Microbiol Immunol; 2006; 50(11):857-65. PubMed ID: 17116980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.
    Shirai M; Okada H; Nishioka M; Akatsuka T; Wychowski C; Houghten R; Pendleton CD; Feinstone SM; Berzofsky JA
    J Virol; 1994 May; 68(5):3334-42. PubMed ID: 7512163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection.
    Koziel MJ; Walker BD
    Springer Semin Immunopathol; 1997; 19(1):69-83. PubMed ID: 9266632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-A2-restricted cytotoxic T lymphocyte activity during interferon beta therapy in patients with chronic hepatitis C.
    Ohira H; Iwasaki M; Takiguchi J; Rai T; Shishido S; Abe K; Takeda J; Tojo J; Sato Y; Kasukawa R
    Fukushima J Med Sci; 2002 Dec; 48(2):75-83. PubMed ID: 12680611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome.
    Wentworth PA; Sette A; Celis E; Sidney J; Southwood S; Crimi C; Stitely S; Keogh E; Wong NC; Livingston B; Alazard D; Vitiello A; Grey HM; Chisari FV; Chesnut RW; Fikes J
    Int Immunol; 1996 May; 8(5):651-9. PubMed ID: 8671652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
    Urbani S; Uggeri J; Matsuura Y; Miyamura T; Penna A; Boni C; Ferrari C
    Hepatology; 2001 Jun; 33(6):1533-43. PubMed ID: 11391544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition.
    Kammer AR; van der Burg SH; Grabscheid B; Hunziker IP; Kwappenberg KM; Reichen J; Melief CJ; Cerny A
    J Exp Med; 1999 Jul; 190(2):169-76. PubMed ID: 10432280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.
    Koziel MJ; Dudley D; Afdhal N; Choo QL; Houghton M; Ralston R; Walker BD
    J Virol; 1993 Dec; 67(12):7522-32. PubMed ID: 7693974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection.
    Kurokohchi K; Arima K; Nishioka M
    J Hepatol; 2001 Jun; 34(6):930-5. PubMed ID: 11451179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL.
    Zhu F; Eckels DD
    Hum Immunol; 2002 Sep; 63(9):710-8. PubMed ID: 12175725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.
    Koziel MJ; Dudley D; Afdhal N; Grakoui A; Rice CM; Choo QL; Houghton M; Walker BD
    J Clin Invest; 1995 Nov; 96(5):2311-21. PubMed ID: 7593618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
    Vertuani S; Bazzaro M; Gualandi G; Micheletti F; Marastoni M; Fortini C; Canella A; Marino M; Tomatis R; Traniello S; Gavioli R
    Eur J Immunol; 2002 Jan; 32(1):144-54. PubMed ID: 11754355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.